|
2024
|
Invention
|
Rifamycin ophthalmic composition and use thereof.
Provided herein are ophthalmic compositions co... |
|
|
Invention
|
Product inhibited from decreasing in content of prostaglandin f2α derivative. The present inventi... |
|
|
Invention
|
Antimicrobial agent. Provided is a novel use of simonkolleite. An antimicrobial agent according t... |
|
2023
|
Invention
|
Rifamycin ophthalmic composition and use thereof. Provided herein are ophthalmic compositions com... |
|
2022
|
Invention
|
Cosmetic for hair growth, raw material for cosmetic, cosmetic, and methods for producing these. [... |
|
|
Invention
|
Therapeutic agent for corneal disease. In recent years, there has been an increased number of cas... |
|
|
Invention
|
Micelle for solubilizing a sparingly water-soluble ingredient and solution comprising the same. T... |
|
2021
|
Invention
|
Ophthalmic composition of rifamycin, and use thereof.
Provided is an ophthalmic composition comp... |
|
|
Invention
|
Ophthalmic composition of rifamycin, and use thereof. [Problem] To provide an ophthalmic composit... |
|
|
Invention
|
Compound useful as toll-like receptor 7 activation inhibitor. CB-7 exhibits a weak TLR7 inhibitin... |
|
|
Invention
|
Novel compound useful as toll-like receptor 7 activation inhibitor. CB-7 exhibits a weak TLR7 inh... |
|
2020
|
Invention
|
Method for obtaining retinal degeneration (rd) model mouse having low risk of causing retinal det... |
|
2019
|
Invention
|
Adeno-associated virus vector. One disadvantage of adeno-associated virus (AAV) is low gene expre... |
|
|
Invention
|
Improved adeno-associated virus vector. One disadvantage of adeno-associated virus (AAV) is low g... |
|
2018
|
Invention
|
Pill container. The purpose of the present invention is to enable a pill to be dispensed by simpl... |
|
|
Invention
|
Sparingly-soluble component solubilized micelle and solution containing same. The purpose of the ... |
|
|
Invention
|
Anti-allergic agent. The purpose of the present invention is to provide a novel anti-allergic age... |
|
2017
|
Invention
|
Composition for controlling in vivo drug dissolution. The present invention addresses the problem... |
|
|
Invention
|
Granular material for orally fast disintegrating tablets. The use of a granular material which is... |
|
|
Invention
|
Granules for orally and rapidly disintegrating tablet. When granules for an orally and rapidly di... |
|
|
Invention
|
Dry-granulated material, solid preparation comprising dry-granulated material and method for manu... |
|
2016
|
Invention
|
External preparation.
The present invention provides an external preparation that exerts excelle... |
|
|
Invention
|
External preparation. The present invention provides an external preparation having an excellent ... |
|
|
Invention
|
Activation inhibitor for toll-like receptor 7 or toll-like receptor 9. In the present invention, ... |
|
|
Invention
|
Therapeutic agent for dry eye associated with sjogren's syndrome. The present invention pertains ... |
|
2015
|
Invention
|
Composition for orally rapidly disintegrating solid preparation. An orally rapidly disintegratin... |
|
2013
|
Invention
|
Drug-containing ultrafine fiber and utilization thereof. The purpose of the present invention is ... |
|
|
Invention
|
Granulated material for tablet that rapidly disintegrates in mouth. A tablet which rapidly disin... |
|
|
Invention
|
Eye drop preparation comprising latanoprost.
It is intended to provide an eye drop preparation c... |
|
2010
|
Invention
|
Remedy for corneal diseases. The present invention provides a method for treating a corneal disea... |
|
|
Invention
|
Therapeutic agent for corneal disease. A therapeutic agent for a corneal disease comprising irsog... |
|
2009
|
Invention
|
Composition for restoring damaged skin comprising a saccaride and povidone-iodine.
The present i... |
|
2008
|
Invention
|
Medicinal composition for transdermal absorption, medicinal composition storing unit and transder... |
|
|
Invention
|
Eye drop preparation comprising latanoprost.
Disclosed is an eye drop preparation comprising lat... |
|
|
Invention
|
Eye drop preparation comprising latanoprost. Disclosed is an eye drop preparation comprising lata... |
|
2007
|
Invention
|
Eye drops container. An eye drops container including a container body filled with a drug solutio... |
|
|
Invention
|
Eye drops container. An eye drops container which can drip chemical solution only under a handsta... |
|
2006
|
Invention
|
Remedy for corneal diseases. To find out drug, by which corneal diseases having been increasing i... |
|
|
Invention
|
Therapeutic agent for corneal disease.
A therapeutic agent for a corneal disease comprising irso... |
|
|
Invention
|
Therapeutic agent for corneal disease. The purpose is to find a substance capable of effectively ... |
|
2005
|
Invention
|
Eye drop composition. An eye drop composition which contains a quaternary ammonium salt in a redu... |
|
2004
|
Invention
|
Cataplasm for repairing damaged skin. A cataplasm for repairing damaged skin characterized in tha... |
|
|
Invention
|
Transdermal absorption preparation containing tulobuterol and patch using the same. A transdermal... |
|
|
Invention
|
Ointment preparation for repairing injured skin. It is intended to provide an ointment preparatio... |
|
|
Invention
|
Diclofenac-containing plaster. A plaster comprising at least a medical agent layer, a base layer ... |
|
2003
|
Invention
|
Composition for restoring damaged skin.
The present invention provides a composition for repairi... |
|
|
Invention
|
Medicines and medicinal kits. It is intended to provide medicines having a higher ocular tension-... |
